Correction: Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples.

Thus, HPV Selfy assay fulfills VALHUDES requirements for use of HR-HPV DNA tests on self-collected samples according to non-inferiority analysis (relative sensitivity > 0.90 with T = B I 1.70 i b , p = B I 0.044 i b ; relative specificity > 0.95 with T = B I 1.87 i b , p = B I 0.031 i b ). B Clinical validation of HPV Selfy on self-collected vaginal samples (VALHUDES) b Next, we aimed at evaluating HPV Selfy performance on self-collected samples, as indicated by VALHUDES protocol. [Extracted from the article]